Whole-genome-sequence-based characterization of an NDM-5-producing uropathogenic Escherichia coli EC1390

• Published in: BMC microbiology Vol. 22; no. 1; p. 150
• Main Authors: Thuy, Tran Thi Dieu, Lu, Hsu-Feng, Kuo, Pei-Yun, Lin, Wei-Hung, Lin, Tzu-Ping, Lee, Yi-Tzu, Duong, Tran Thi Thuy, Wang, Ming-Cheng, Lee, Yi-Hong, Wen, Li-Li, Chen, Yu-Chen, Kao, Cheng-Yen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 06-06-2022; BioMed Central; BMC
• Subjects: Adhesion; Analysis; Annotations; Antibiotics; Antimicrobial agents; Antimicrobial resistance; Assaying; Bacteria; Bacterial diseases; Bacterial infections; Beta lactam antibiotics; Biofilms; bla NDM-5; Care and treatment; Cell adhesion; Colistin; Conjugation; CRISPR; Diagnosis; DNA sequencing; Dosage and administration; Drug resistance; Drug resistance in microorganisms; E coli; Escherichia coli; Extensively-drug resistant; Gene sequencing; Genes; Genomes; Growth rate; Infections; Iron; Laboratories; Nucleotide sequence; Nucleotide sequencing; Nutrition; Pathogens; Patients; Phylogeny; Plasmids; Prevention; Risk factors; Tigecycline; Urinary tract; Urinary tract infection; Urinary tract infections; Virulence; Virulence (Microbiology); Whole genome sequencing; Taiwan; United States > US; Urinary tract infection; bla NDM-5; Extensively-drug resistant; Whole-genome sequencing; Virulence
• ISSN: 1471-2180; 1471-2180
• DOI: 10.1186/s12866-022-02562-6

Urinary tract infection (UTI) is one of the most common outpatient bacterial infections. In this study, we isolated and characterized an extensively-drug resistant (XDR) NDM-5-producing Escherichia coli EC1390 from a UTI patient by using whole-genome sequencing (WGS) in combination with phenotypic assays.
Antimicrobial susceptibility to 23 drugs was determined by disk diffusion method. The genome sequence of EC1390 was determined by Nanopore MinION MK1C platform. Conjugation assays were performed to test the transferability of EC1390 plasmids to E. coli recipient C600. Phenotypic assays, including growth curve, biofilm formation, iron acquisition ability, and cell adhesion, were performed to characterize the function of EC1390 plasmids.
Our results showed that EC1390 was only susceptible to tigecycline and colistin, and thus was classified as XDR E. coli. A de novo genome assembly was generated using Nanopore 73,050 reads with an N
 value of 20,936 bp and an N
 value of 7,624 bp. WGS analysis showed that EC1390 belonged to the O101-H10 serotype and phylogenetic group A E. coli. Moreover, EC1390 contained 2 conjugative plasmids with a replicon IncFIA (pEC1390-1 with 156,286 bp) and IncFII (pEC1390-2 with 71,840 bp), respectively. No significant difference was observed in the bacterial growth rate in LB broth and iron acquisition ability between C600, C600 containing pEC1390-1, C600 containing pEC1390-2, and C600 containing pEC1390-1 and pEC1390-2. However, the bacterial growth rate in nutrition-limited M9 broth was increased in C600 containing pEC1390-2, and the cell adhesion ability was increased in C600 containing both pEC1390-1 and pEC1390-2. Moreover, these plasmids modulated the biofilm formation under different conditions.
In summary, we characterized the genome of XDR-E. coli EC1390 and identified two plasmids contributing to the antimicrobial resistance, growth of bacteria in a nutrition-limited medium, biofilm formation, and cell adhesion.